Carotid artery atherosclerosis is a major risk factor for both stroke and cardiovascular disease. Appropriate management of asymptomatic patients with carotid artery stenosis (CAS) remains unclear. Although several randomized clinical trials support revascularization in asymptomatic patients with severe CAS to reduce stroke risk, the participants in these trials did not receive optimal medical therapy (OMT) by today's standards. For many individuals, medical therapy may provide excellent risk reduction without the periprocedural risk of endarterectomy or stenting. In this review, we discuss the risk factors for CAS and stroke and examine the data for each component of OMT in these patients.
|Original language||English (US)|
|Number of pages||6|
|Journal||Progress in Cardiovascular Diseases|
|State||Published - May 2017|
- Carotid artery stenosis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine